Lycia Therapeutics(LYCA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LYCA Lycia Therapeutics

休市中 10-23 16:00:00 EDT

30.00

+12.00

+66.67%

盘后26.50

-3.50-11.67%

19:59 EDT

最高36.49	最低22.19	成交量228.72万
今开28.55	昨收18.00	日振幅79.46%
总市值15.63亿	流通市值4.41亿	总股本5,209万
成交额6,326万	换手率15.56%	流通股本1,470万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"LYCA","market":"US","secType":"STK","nameCN":"Lycia Therapeutics","latestPrice":30,"timestamp":1792785600000,"preClose":18,"halted":0,"volume":2287202,"hourTrading":{"tag":"盘后","latestPrice":26.5,"preClose":30,"latestTime":"19:59 EDT","volume":21598,"amount":605931.297,"timestamp":1792799969687,"change":-3.5,"changeRate":-0.116667,"amplitude":0.116667},"delay":0,"changeRate":0.6666666666666666,"floatShares":14700000,"shares":52094559,"eps":0,"marketStatus":"休市中","change":12,"latestTime":"10-23 16:00:00 EDT","open":28.55,"high":36.4931,"low":22.19,"amount":63259412.331181996,"amplitude":0.794617,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1793001600000},"marketStatusCode":7,"adr":0,"listingDate":1792728000000,"exchange":"NASDAQ","adjPreClose":18,"postHourTrading":{"tag":"盘后","latestPrice":26.5,"preClose":30,"latestTime":"19:59 EDT","volume":21598,"amount":605931.297,"timestamp":1792799969687,"change":-3.5,"changeRate":-0.116667,"amplitude":0.116667},"volumeRatio":0},"requestUrl":"/m/hq/s/LYCA/wiki","defaultTab":"wiki","newsList":[{"id":"2677979350","title":"美股异动 | 生物科技公司Lycia Therapeutics(LYCA.US)登陆美股市场 股价涨超32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677979350","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677979350?lang=zh_cn&edition=full","pubTime":"2026-10-24 00:27","pubTimestamp":1792772851,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周五，专注于过敏和自身免疫性疾病治疗的生物科技公司Lycia Therapeutics(LYCA.US)登陆美股市场，开盘后股价涨超32%，报23.9美元。IPO价格为18美元。Lycia Therapeutics致力于开发旨在降解致病细胞外蛋白的疗法，初期聚焦自身免疫、炎症和过敏性疾病。其技术平台名为LYTAC(溶酶体靶向嵌合体)，基于诺贝尔奖得主Carolyn Bertozzi在斯坦福大学的研究工作。其主要候选药物LCA-0061旨在降解免疫球蛋白E(IgE)，用于治疗包括食物过敏在内的过敏性疾病，目前处于一期临床试验阶段。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1511943.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MEDX","LNGR","BK4139","159837","SYNB","HBImain","BK4007","AGNG","BK4539","BK4581","BK4585","GDOC","BK4588","IEIH","LENZ","LYCA","XBI","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677919112","title":"过敏及自免生物技术公司Lycia Therapeutics(LYCA.US)今晚登陆纳斯达克！IPO定价18美元/股 拟募资3.175亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677919112","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677919112?lang=zh_cn&edition=full","pubTime":"2026-10-23 10:34","pubTimestamp":1792722852,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LYCA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677280556","title":"过敏及自免生物技术公司Lycia Therapeutics(LYCA.US)IPO定价16-18美元/股 拟募资2.5亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677280556","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677280556?lang=zh_cn&edition=full","pubTime":"2026-10-21 14:57","pubTimestamp":1792565853,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，生物技术公司Lycia Therapeutics周二公布首次公开募股条款。按拟议发行价区间中点计算，Lycia Therapeutics的完全稀释市值将达到约9.5亿美元。Lycia Therapeutics致力于开发旨在降解致病细胞外蛋白的疗法，初期聚焦自身免疫、炎症和过敏性疾病。此外，公司正在开展LCA-0321的一期临床试验，该药物旨在选择性降解引发格雷夫斯病的自身抗体。Lycia Therapeutics成立于2019年，截至2026年6月30日的12个月内实现营收400万美元。预计10月19日当周定价。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1510011.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["UDN","IPOS","LYCA","BK4139","HELX","BK4539","LENZ","UUP","WDNA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lyciatx.com","stockEarnings":[{"period":"1week","weight":0.6667},{"period":"ytd","weight":0.6667}],"compareEarnings":[{"period":"1week","weight":-0.0043},{"period":"1month","weight":-0.0102},{"period":"3month","weight":0.0285},{"period":"6month","weight":0.0645},{"period":"1year","weight":0.1313},{"period":"ytd","weight":0.1145}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lycia Therapeutics, Inc.于2019年10月24日根据特拉华州法律注册成立。该公司是一家处于临床阶段的生物技术公司，致力于发现和开发旨在降解致病性细胞外蛋白的新型疗法，初期重点关注自身免疫性疾病、炎症性疾病和过敏性疾病。利用其专有的LYTAC平台，公司开发了一系列候选疗法，有望针对现有疗法未能有效应对的细胞外蛋白实现深度且持久的清除。公司正通过一项旨在确立早期概念验证（包括药效学和生物标志物数据）的临床开发策略推进这些候选药物，以评估靶点调节情况并为进入后期开发提供依据。其IgE产品管线包含旨在降解IgE以治疗过敏性疾病（包括食物过敏）的候选药物。","exchange":"NASDAQ","name":"Lycia Therapeutics","nameEN":"Lycia Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Lycia Therapeutics(LYCA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Lycia Therapeutics(LYCA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Lycia Therapeutics,LYCA,Lycia Therapeutics股票,Lycia Therapeutics股票老虎,Lycia Therapeutics股票老虎国际,Lycia Therapeutics行情,Lycia Therapeutics股票行情,Lycia Therapeutics股价,Lycia Therapeutics股市,Lycia Therapeutics股票价格,Lycia Therapeutics股票交易,Lycia Therapeutics股票购买,Lycia Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Lycia Therapeutics(LYCA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Lycia Therapeutics(LYCA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}